Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone

References

• Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi:10.1210/er.2018-00242
   PubMed Web of Science ®Google Scholar
• Saunders PT, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):2807–2824. doi:10.1016/j.cell.2021.04.041
   PubMed Web of Science ®Google Scholar
• Donnez J, Cacciottola L. Endometriosis: an inflammatory disease that requires new therapeutic options. Int J Mol Sci. 2022;23(3):1518. doi:10.3390/ijms23031518
   PubMed Web of Science ®Google Scholar
• Facchin F, Barbara G, Saita E, et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol. 2015;36(4):135–141. doi:10.3109/0167482X.2015.1074173
   PubMed Web of Science ®Google Scholar
• Hogg C, Horne AW, Greaves E. Endometriosis-associated macrophages: origin, phenotype, and function. Front Endocrinol. 2020;11:7. doi:10.3389/fendo.2020.00007
   PubMed Web of Science ®Google Scholar
• D’Alterio MN, Saponara S, D’Ancona G, et al. Role of surgical treatment in endometriosis. Minerva Obstet Gynecol. 2021;73(3):317–332. doi:10.23736/S2724-606X.21.04737-7
   PubMedGoogle Scholar
• Davis SR, Wahlin-Jacobsen S. Testosterone in women—the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980–992. doi:10.1016/S2213-8587(15)00284-3
   PubMed Web of Science ®Google Scholar
• Walters KA, Paris VR, Aflatounian A, Handelsman DJ. Androgens and ovarian function: translation from basic discovery research to clinical impact. J Endocrinol. 2019;242(2):R23–R50. doi:10.1530/JOE-19-0096
   PubMed Web of Science ®Google Scholar
• Gibson DA, Simitsidellis I, Collins F, Saunders PT. Androgens, oestrogens and endometrium: a fine balance between perfection and pathology. J Endocrinol. 2020;246(3):R75–R93. doi:10.1530/JOE-20-0106
   PubMed Web of Science ®Google Scholar
• Bianchi VE, Bresciani E, Meanti R, Rizzi L, Omeljaniuk RJ, Torsello A. The role of androgens in women’s health and wellbeing. Pharmacol Res. 2021;171:105758. doi:10.1016/j.phrs.2021.105758
   PubMed Web of Science ®Google Scholar
• Rey R, Josso N, Racine C. Sexual differentiation. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext [Internet]. MDText.com, Inc.; 2020. Available from:: https://www.ncbi.nlm.nih.gov/books/NBK279001/. Accessed January 22, 2023.
   Google Scholar
• Thankamony A, Pasterski V, Ong KK, Acerini CL, Hughes IA. Anogenital distance as a marker of androgen exposure in humans. Andrology. 2016;4(4):616–625. doi:10.1111/andr.12156
   PubMed Web of Science ®Google Scholar
• Singal AK, Jain VG. Maternal and infant characteristics influencing the anogenital distance and penile length in newborns. Andrologia. 2016;48(6):708–713. doi:10.1111/and.12507
   PubMed Web of Science ®Google Scholar
• Mendiola J, Sánchez-Ferrer ML, Jiménez-Velázquez R, et al. Endometriomas and deep infiltrating endometriosis in adulthood are strongly associated with anogenital distance, a biomarker for prenatal hormonal environment. Hum Reprod. 2016;31(10):2377–2383. doi:10.1093/humrep/dew163
   PubMed Web of Science ®Google Scholar
• Sánchez-Ferrer ML, Mendiola J, Jiménez-Velázquez R, et al. Investigation of anogenital distance as a diagnostic tool in endometriosis. Reprod BioMed Online. 2017;34(4):375–382. doi:10.1016/j.rbmo.2017.01.002
   PubMed Web of Science ®Google Scholar
• Sánchez‐Ferrer ML, Jiménez‐Velázquez R, Mendiola J, et al. Accuracy of anogenital distance and anti‐Müllerian hormone in the diagnosis of endometriosis without surgery. Int J Gynecol Obstet. 2019;144(1):90–96. doi:10.1002/ijgo.12691
   PubMed Web of Science ®Google Scholar
• Peters HE, Laeven CH, Trimbos CJ, et al. Anthropometric biomarkers for abnormal prenatal reproductive hormone exposure in women with Mayer-Rokitanksy-Küster-Hauser syndrome, polycystic ovary syndrome, and endometriosis. Fertil Steril. 2020;114(6):1297–1305. doi:10.1016/j.fertnstert.2020.06.029
   PubMed Web of Science ®Google Scholar
• Crestani A, Arfi A, Ploteau S, et al. Anogenital distance in adult women is a strong marker of endometriosis: results of a prospective study with laparoscopic and histological findings. Hum Reprod Open. 2020;2020(3):hoaa023. doi:10.1093/hropen/hoaa023
   PubMedGoogle Scholar
• Crestani A, Abdel Wahab C, Arfi A, et al. A short anogenital distance on MRI is a marker of endometriosis. Hum Reprod Open. 2021;2021(1):hoab003. doi:10.1093/hropen/hoab003
   PubMedGoogle Scholar
• Buggio L, Somigliana E, Sergenti G, Ottolini F, Dridi D, Vercellini P. Anogenital distance and endometriosis: results of a case–control study. Reprod Sci. 2022;1–8. doi:10.1007/s43032-022-01009-7
   Web of Science ®Google Scholar
• Pan Z, Zhu F, Zhou K. A systematic review of anogenital distance and gynecological disorders: endometriosis and polycystic ovary syndrome. Front Endocrinol. 2021;12. doi:10.3389/fendo.2021.696879
   Web of Science ®Google Scholar
• Fabregues F, González-Foruria I, Peñarrubia J, Carmona F. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF. Hum Reprod. 2018;33(9):1696–1704. doi:10.1093/humrep/dey244
   PubMed Web of Science ®Google Scholar
• Dural O, Kurbanova T, Yasa C, et al. Idiopathic primary ovarian insufficiency is associated with anogenital distance, a marker for prenatal environment. Eur J Obstet Gynecol Reprod Biol. 2021;258:304–308. doi:10.1016/j.ejogrb.2021.01.017
   PubMed Web of Science ®Google Scholar
• Mira-Escolano MP, Mendiola J, Mínguez-Alarcón L, et al. Anogenital distance of women in relation to their mother’s gynaecological characteristics before or during pregnancy. Reprod BioMed Online. 2014a;28(2):209–215. doi:10.1016/j.rbmo.2013.09.026
   PubMed Web of Science ®Google Scholar
• Mendiola J, Roca M, Mínguez-Alarcón L, et al. Anogenital distance is related to ovarian follicular number in young Spanish women: a cross-sectional study. Environ Health. 2012;11(1):1–8. doi:10.1186/1476-069X-11-90
   PubMedGoogle Scholar
• Mira‐Escolano MP, Mendiola J, Mínguez‐Alarcón L, et al. Longer anogenital distance is associated with higher testosterone levels in women: a cross‐sectional study. BJOG. 2014b;121(11):1359–1364. doi:10.1111/1471-0528.12627
   PubMed Web of Science ®Google Scholar
• Crespi B, Dinsdale NL. The sexual selection of endometriosis. Evol Behav Sci. 2021. doi:10.1037/ebs0000275
   Google Scholar
• Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1–5. doi:10.1016/j.bpobgyn.2018.06.001
   PubMed Web of Science ®Google Scholar
• Ponomarenko I, Reshetnikov E, Polonikov A, et al. Candidate genes for age at menarche are associated with endometriosis. Reprod BioMed Online. 2020;41(5):943–956. doi:10.1016/j.rbmo.2020.04.016
   PubMed Web of Science ®Google Scholar
• Dinsdale N, Nepomnaschy P, Crespi B. The evolutionary biology of endometriosis. Evol Med Public Health. 2021;9(1):174–191. doi:10.1093/emph/eoab008
   PubMed Web of Science ®Google Scholar
• Berlanda N, Alio W, Angioni S, et al. Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian study. Arch Gynecol Obstet. 2022;305(1):149–157. doi:10.1007/s00404-021-06243-z
   PubMed Web of Science ®Google Scholar
• Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl. 2021;14(7):1693–1715. doi:10.1111/eva.13244
   PubMed Web of Science ®Google Scholar
• Holoch KJ, Moorhead A, Miller PB, Higdon HL, Likes CE, Lessey BA. Endometriosis in women with polycystic ovary syndrome (PCOS) and its role in poor reproductive outcomes. Fertil Steril. 2011;96(3):S133. doi:10.1016/j.fertnstert.2011.07.518
   Web of Science ®Google Scholar
• Zondervan KT, Rahmioglu N, Morris AP, et al. Beyond endometriosis genome-wide association study: from genomics to phenomics to the patient. Semin Reprod Med. 2016;34(04):242–254. doi:10.1055/s-0036-1585408
   PubMedGoogle Scholar
• Sapkota Y, Steinthorsdottir V, Morris AP, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun. 2017;8(1):1–12. doi:10.1038/ncomms15539
   PubMedGoogle Scholar
• McGrath IM, Mortlock S, Montgomery GW. Genetic regulation of physiological reproductive lifespan and female fertility. Int J Mol Sci. 2021;22(5):2556. doi:10.3390/ijms22052556
   PubMed Web of Science ®Google Scholar
• Hong SH, Hong YS, Jeong K, Chung H, Lee H, Sung YA. Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes. Sci Rep. 2020;10(1):1–8. doi:10.1038/s41598-020-66633-2
   PubMed Web of Science ®Google Scholar
• Garitazelaia A, Rueda-Martínez A, Arauzo R, et al. A systematic two-sample Mendelian randomization analysis identifies shared genetic origin of endometriosis and associated phenotypes. Life. 2021;11(1):24. doi:10.3390/life11010024
   PubMedGoogle Scholar
• Pinola P, Morin-Papunen LC, Bloigu A, et al. Anti-Müllerian hormone: correlation with testosterone and oligo-or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod. 2014;29(10):2317–2325. doi:10.1093/humrep/deu182
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Skiba MA, Davis SR. Testosterone and androstenedione are positively associated with anti‐Müllerian hormone in premenopausal women. Clin Endocrinol. 2021;95(5):752–759. doi:10.1111/cen.14592
   PubMed Web of Science ®Google Scholar
• Sidhu S, Parikh T, Burman KD. Endocrine changes in obesity. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext [Internet]. MDText.com, Inc.; 2000. Available from:: https://www.ncbi.nlm.nih.gov/books/NBK279053/. Accessed January 22, 2023.
   Google Scholar
• Stanikova D, Zsido RG, Luck T, et al. Testosterone imbalance may link depression and increased body weight in premenopausal women. Transl Psychiatry. 2019;9(1):1–2. doi:10.1038/s41398-019-0487-5
   PubMedGoogle Scholar
• Heilier J-F, Donnez J, Nackers F, et al. Environmental and host-associated risk factors in endometriosis and deep endometriotic nodules: a matched case–control study. Environ Res. 2007;103(1):121–129. doi:10.1016/j.envres.2006.04.004
   PubMed Web of Science ®Google Scholar
• Porpora MG, Medda E, Abballe A, et al. Endometriosis and organochlorinated environmental pollutants: a case-control study on Italian women of reproductive age. Environ Health Perspect. 2009;117(7):1070–1075. doi:10.1289/ehp.0800273
   PubMed Web of Science ®Google Scholar
• Ottolina J, Schimberni M, Makieva S, et al. Early-life factors, in-utero exposures and endometriosis risk: a meta-analysis. Reprod Bio Med. 2020;41(2):279–289. doi:10.1016/j.rbmo.2020.04.005
   Google Scholar
• Christiansen S, Axelstad M, Boberg J, Vinggaard AM, Pedersen GA, Hass U. Low-dose effects of bisphenol A on early sexual development in male and female rats. Reproduction. 2014;147(4):477–487. doi:10.1530/REP-13-0377
   PubMed Web of Science ®Google Scholar
• Pivonello C, Muscogiuri G, Nardone A, et al. Bisphenol A: an emerging threat to female fertility. Reprod Biol Endocrinol. 2020;18(1):1–33. doi:10.1186/s12958-019-0558-8
   PubMed Web of Science ®Google Scholar
• Barrett ES, Sathyanarayana S, Mbowe O, et al. First-trimester urinary bisphenol A concentration in relation to anogenital distance, an androgen-sensitive measure of reproductive development, in infant girls. Environ Health Perspect. 2017;125(7):077008. doi:10.1289/EHP875
   PubMed Web of Science ®Google Scholar
• Swan SH, Kristensen DM. Anogenital distance: a marker of steroidal endocrine disruption. Andrology. 2018;30:963b72. doi:10.1016/B978-0-12-801238-3.64379-9
   Google Scholar
• Cai W, Yang J, Liu Y, Bi Y, Wang H. Association between phthalate metabolites and risk of endometriosis: a meta-analysis. Int J Environ Res Public Health. 2019;16(19):3678. doi:10.3390/ijerph16193678
   PubMed Web of Science ®Google Scholar
• van Aken M, Oosterman J, van Rijn T, et al. Experimental pain tolerance is decreased and independent of clinical pain intensity in patients with endometriosis. Fertil Steril. 2018;110(6):1118–1128. doi:10.1016/j.fertnstert.2018.06.040
   PubMed Web of Science ®Google Scholar
• Casale R, Atzeni F, Bazzichi L, et al. Pain in women: a perspective review on a relevant clinical issue that deserves prioritization. Pain Ther. 2021;10(1):287–314. doi:10.1007/s40122-021-00244-1
   PubMed Web of Science ®Google Scholar
• Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod. 2007;22(1):266–271. doi:10.1093/humrep/del339
   PubMed Web of Science ®Google Scholar
• Bartley EJ, Palit S, Kuhn BL, et al. Natural variation in testosterone is associated with hypoalgesia in healthy women. Clin J Pain. 2015;31(8):730–739. doi:10.1097/AJP.0000000000000153
   PubMed Web of Science ®Google Scholar
• Evans SF, Hull ML, Hutchinson MR, Rolan PE. Androgens, endometriosis and pain. Front Reprod Health. 2021a;3:792920. doi:10.3389/frph.2021.792920
   PubMedGoogle Scholar
• Evans SF, Kwok Y, Solterbeck A, et al. The relationship between androgens and days per month of period pain, pelvic pain, headache, and TLR4 responsiveness of peripheral blood mononuclear cells in young women with dysmenorrhoea. J Pain Res. 2021b;14:585. doi:10.2147/JPR.S279253
   PubMed Web of Science ®Google Scholar
• Aloisi AM, Bachiocco V, Costantino A, et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain. 2007;132(Supplement 1):S60–S67. doi:10.1016/j.pain.2007.02.006
   PubMedGoogle Scholar
• Smith HS, Elliott JA. Opioid-induced androgen deficiency (OPIAD). Pain Physician. 2012;15(3S):ES145.
   PubMedGoogle Scholar
• White HD, Robinson TD. A novel use for testosterone to treat central sensitization of chronic pain in fibromyalgia patients. Int Immunopharmacol. 2015;27(2):244–248. doi:10.1016/j.intimp.2015.05.020
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Nock B, O’Connor L, Meyer ER. Role of steroids in sex differences in morphine-induced analgesia: activational and organizational effects. J Pharmacol Exp Ther. 2002;300(2):695–701. doi:10.1124/jpet.300.2.695
   PubMed Web of Science ®Google Scholar
• García-Gómez E, Vázquez-Martínez ER, Reyes-Mayoral C, Cruz-Orozco OP, Camacho-Arroyo I, Cerbón M. Regulation of inflammation pathways and inflammasome by sex steroid hormones in endometriosis. Front Endocrinol. 2020;10:935. doi:10.3389/fendo.2019.00935
   PubMed Web of Science ®Google Scholar
• Ben-Batalla I, Vargas-Delgado ME, von Amsberg G, Janning M, Loges S. Influence of androgens on immunity to self and foreign: effects on immunity and cancer. Front Immunol. 2020;11:1184. doi:10.3389/fimmu.2020.01184
   PubMed Web of Science ®Google Scholar
• Klein S, Flanagan K. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638. doi:10.1038/nri.2016.90
   PubMed Web of Science ®Google Scholar
• Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann NY Acad Sci. 2002;966(1):131–142. doi:10.1111/j.1749-6632.2002.tb04210.x
   PubMedGoogle Scholar
• Dane Ş, Timur H. Sex-related differences in tuberculin reaction, free and total testosterone concentrations in patients with autoimmune disorders and controls. Int J Neurosci. 2005;115(6):911–916. doi:10.1080/00207450590882190
   PubMed Web of Science ®Google Scholar
• Benagiano M, Bianchi P, D’Elios MM, Brosens I, Benagiano G. Autoimmune diseases: role of steroid hormones. Best Pract Res Clin Obstet Gynaecol. 2019;60:24–34. doi:10.1016/j.bpobgyn.2019.03.001
   PubMed Web of Science ®Google Scholar
• Zhang T, De Carolis C, Man GCW, Wang CC. The link between immunity, autoimmunity and endometriosis: a literature update. Autoimmun Rev. 2018;17(10):945–955. doi:10.1016/j.autrev.2018.03.017
   PubMed Web of Science ®Google Scholar
• Shigesi N, Kvaskoff M, Kirtley S, et al. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):486–503. doi:10.1093/humupd/dmz014
   PubMed Web of Science ®Google Scholar
• Porpora MG, Scaramuzzino S, Sangiuliano C, et al. High prevalence of autoimmune diseases in women with endometriosis: a case-control study. Gynecol Endocrinol. 2020;36(4):356–359. doi:10.1080/09513590.2019.1655727
   PubMed Web of Science ®Google Scholar
• Pluchino N, Ninni F, Casarosa E, et al. Sex differences in brain and plasma β-endorphin content following testosterone, dihydrotestosterone and estradiol administration to gonadectomized rats. Neuroendocrinology. 2009;89(4):411–423. doi:10.1159/000209506
   PubMed Web of Science ®Google Scholar
• Wortsman JA, Wehrenberg WB, Gavin JR, Allen JP. Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstet Gynecol. 1984;63(5):630–634.
   PubMed Web of Science ®Google Scholar
• Aleem FA, Eltabbakh GH, Omar RA, Southren AL. Ovarian follicular fluid β-endorphin levels in normal and polycystic ovaries. Am J Obstet Gynecol. 1987;156(5):1197–1200. doi:10.1016/0002-9378(87)90143-8
   PubMed Web of Science ®Google Scholar
• Carmina E, Ditkoff EC, Malizia G, Vijod AG, Janni A, Lobo RA. Increased circulating levels of immunoreactive β-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am J Obstet Gynecol. 1992;167(6):1819–1824. doi:10.1016/0002-9378(92)91781-5
   PubMed Web of Science ®Google Scholar
• Kialka M, Milewicz T, Mrozinska S, Sztefko K, Rogatko I, Majewska R. Pressure pain threshold and [beta]-endorphins plasma level are higher in lean polycystic ovary syndrome women. Endocr Abstr. 2016;41. doi:10.1530/endoabs.41.EP751
   Google Scholar
• Martinez-Guisasola J, Ferrer J, Guerrero M, et al. Circulating levels of immunoreactive β-endorphin in polycystic ovary syndrome. Gynecol Endocrinol. 1999;13(1):26–35. doi:10.1080/09513599909167528
   PubMed Web of Science ®Google Scholar
• Jaschke N, Lunger F, Wildt L, Seeber B. Beta endorphin in serum and follicular fluid of PCOS-and non-PCOS women. Arch Gynecol Obstet. 2018;298(1):217–222. doi:10.1007/s00404-018-4793-6
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Bersi C, Parrini D, Ricci C, Genazzani AR. Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil Steril. 2002;77(5):936–944. doi:10.1016/S0015-0282(02)02955-2
   PubMed Web of Science ®Google Scholar
• Ahmed MI, Duleba AJ, El Shahat O, Ibrahim ME, Salem A. Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Hum Reprod. 2008;23(11):2564–2569. doi:10.1093/humrep/den273
   PubMed Web of Science ®Google Scholar
• Boettcher B, Seeber B, Leyendecker G, Wildt L. Impact of the opioid system on the reproductive axis. Fertil Steril. 2017;108(2):207–213. doi:10.1016/j.fertnstert.2017.06.009
   PubMed Web of Science ®Google Scholar
• Duan H, Ge W, Yang S, et al. Dihydrotestosterone regulates oestrogen secretion, oestrogen receptor expression, and apoptosis in granulosa cells during antral follicle development. J Steroid Biochem Mol Biol. 2021;207:105819. doi:10.1016/j.jsbmb.2021.105819
   PubMed Web of Science ®Google Scholar
• Ono YJ, Tanabe A, Nakamura Y, et al. A low-testosterone state associated with endometrioma leads to the apoptosis of granulosa cells. PLoS One. 2014;9(12):e115618. doi:10.1371/journal.pone.0115618
   PubMed Web of Science ®Google Scholar
• Huang L, Chen M, Long L, et al. Low basal serum testosterone level is detrimental to the embryo implantation in the patients with severe endometriosis. J Obstet Gynaecol Res. 2021;47(6):2166–2174. doi:10.1111/jog.14791
   PubMed Web of Science ®Google Scholar
• Soman M, Huang LC, Cai WH, et al. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. Menopause. 2019;26(1):78. doi:10.1097/GME.0000000000001161
   PubMed Web of Science ®Google Scholar
• Noventa M, Vitagliano A, Andrisani A, et al. Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials. J Assist Reprod Genet. 2019;36(4):673–683. doi:10.1007/s10815-018-1383-2
   PubMed Web of Science ®Google Scholar
• Kallak TK, Hellgren C, Skalkidou A, et al. Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain. Eur J Endocrinol. 2017;177(4):379–388. doi:10.1530/EJE-17-0207
   PubMed Web of Science ®Google Scholar
• Ho SM, Cheong A, Adgent MA, et al. Environmental factors, epigenetics, and developmental origin of reproductive disorders. Reprod Toxicol. 2017;68:85–104. doi:10.1016/j.reprotox.2016.07.011
   PubMed Web of Science ®Google Scholar
• Cernea M, Padmanabhan V, Goodman RL, Coolen LM, Lehman MN. Prenatal testosterone treatment leads to changes in the morphology of KNDy neurons, their inputs, and projections to GnRH cells in female sheep. Endocrinology. 2015;156(9):3277–3291. doi:10.1210/en.2014-1609
   PubMed Web of Science ®Google Scholar
• Stener-Victorin E, Padmanabhan V, Walters KA, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4):bnaa010. doi:10.1210/endrev/bnaa010
   PubMed Web of Science ®Google Scholar
• Risal S, Pei Y, Lu H, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894–1904. doi:10.1038/s41591-019-0666-1
   PubMed Web of Science ®Google Scholar
• Parker J, O’Brien C, Gersh FL. Developmental origins and transgenerational inheritance of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2021;61(6):922–926. doi:10.1111/ajo.13420
   PubMed Web of Science ®Google Scholar
• Ashfaq S, Can AS. Danazol. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564344/. Accessed January 22, 2023.
   Google Scholar
• Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol. 1981;139(6):645–654. doi:10.1016/0002-9378(81)90478-6
   PubMed Web of Science ®Google Scholar
• Mifflin KA, Kerr BJ. Pain in autoimmune disorders. J Neurosci Res. 2017;95(6):1282–1294. doi:10.1002/jnr.23844
   PubMed Web of Science ®Google Scholar
• Tomassini V, Onesti E, Mainero C, et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry. 2005;76(2):272–275. doi:10.1136/jnnp.2003.033324
   PubMed Web of Science ®Google Scholar
• Nagae M, Uenoyama Y, Okamoto S, et al. Direct evidence that KNDy neurons maintain gonadotropin pulses and folliculogenesis as the GnRH pulse generator. Proc Natl Acad Sci USA. 2021;118(5):e2009156118. doi:10.1073/pnas.2009156118
   PubMed Web of Science ®Google Scholar